Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
64.00    2.00 (3.23%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £15.59m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Board Changes

23 Mar 2021 07:00

RNS Number : 1045T
MyCelx Technologies Corporation
23 March 2021
 

23 March 2021

 

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

 

Board Changes

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology experts, announces that Tim Eggar intends to step down from his role as Non-Executive Chairman at the Annual General Meeting to be held in July 2021.

 

Mr. Eggar joined MYCELX in 2011, steering the Company through its IPO, growth, and the recent challenging period. His considerable experience in the Energy sector and international business expertise has been invaluable in establishing the Company as a leading provider of sustainable water treatment solutions to the global market.

 

Mr. Tom Lamb, Non-Executive Director, Chairman of the Compensation Committee, and a member of the Audit and Nomination Committees, will assume the role of Chairman following Mr. Eggar's departure.

 

Mr. Lamb joined the Board in July 2019, bringing a wealth of strategic and operating expertise in a broad range of roles across the industrial and technology sectors. He has spent over 30 years driving organic growth and leading businesses in multiple international settings, including serving in a number of executive leadership roles in both public and private companies.

 

The Company will continue to review the balance of the board and would consider making a further Independent Non-Executive Director appointment in due course such that the Board has three Independent Directors including the Chairman.

 

Mr. Eggar, out-going Non-Executive Chairman, said:

 

"Following the Company's successful navigation of the COVID-19 pandemic, the time is right for me to step down from the Board of MYCELX. I have greatly enjoyed my time at the Company, and the opportunities it has given me to support its development. I leave knowing that the business is well placed to capture the very significant opportunity that exists in delivering clean water and air solutions, and helping our customers to achieve their sustainability goals. The next chapter of the MYCELX story is set to be a very exciting one, and I leave the Company in the safest of hands at both Board and senior management levels. I am grateful for the support I have received during my tenure, and look forward to watching MYCELX's continued success."

 

Connie Mixon, CEO, said:

 

"On behalf of us all at MYCELX, I would like to thank Tim for his many years of insightful support of the Company. Under his guidance, MYCELX has expanded into new territories and diversified its patented product offering. As the global economic recovery takes shape, MYCELX is well placed to benefit from a resurgence in bidding activity in the oil and gas sector, in addition to the other markets where we operate. Tim has been instrumental in helping us get to where we are today, empowering leadership to take the company in new directions, and we owe him a considerable debt of gratitude.

 

We are pleased to have a successor of Tom's calibre, and look forward to his continuing strong support as he assumes the role of Chairman."

 

 

 

For further information please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity, Nominated Adviser

Henry Fitzgerald-O'Connor

Georgina McCooke

 

 

Tel: + 44 20 7523 8000

Celicourt

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

Notes to Editors

Through its revolutionary oil-free water technology, MYCELX brings its customers material benefits in terms of performance enhancement, cost savings and significantly improved environmental footprints. Working beyond any ordinary filtration methods, MYCELX's proprietary technology achieves oil removal to less than one part per million. MYCELX supports leading international customers across the oil & gas value chain, as well as other industrial users. MYCELX also provides advanced air filtration technology for manufacturing and industrial facilities, effectively removing oil particles and biologicals to maintain continuous and safe air quality levels.

For more information, visit www.MYCELX.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKBBQCBKDNNB
Date   Source Headline
10th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSRestricted Common Shares to be Traded in CREST
20th Aug 20157:00 amRNSDirector Resignation
17th Aug 20157:00 amRNSProgress Report on Trials and Cost Reduction
29th Jul 20152:01 pmRNSHolding(s) in Company
22nd Jul 20157:00 amRNSTrading Statement
1st Jul 20157:00 amRNSChange of Adviser
5th Jun 20157:00 amRNSDirector/PDMR Shareholding
28th May 20159:48 amRNSBlocklisting Interim Review
21st May 20153:01 pmRNSDirector/PDMR Shareholding
19th May 20154:01 pmRNSResult of Annual Meeting
19th May 20157:00 amRNSAnnual Meeting Statement
17th Apr 20157:00 amRNSMailing of 2014 Annual Report & Notice of AGM
20th Mar 20157:00 amRNS2014 Preliminary Results
15th Jan 20155:39 pmRNSTrading Update
5th Jan 20157:00 amRNSClose of US Placing
2nd Jan 201512:00 pmRNSHolding(s) in Company
22nd Dec 201412:54 pmRNSHolding(s) in Company
10th Dec 20147:00 amRNSEquity Placing
2nd Dec 20147:00 amRNSEquity Placing
27th Nov 20143:58 pmRNSBlocklisting Interim Review
19th Nov 20147:00 amRNSTrading Statement
12th Sep 20147:00 amRNSHalf Year Results Statement
26th Aug 20147:00 amRNSMiddle East Contract Win
7th Jul 20147:00 amRNSHalf Year Trading Update & Contract Wins
13th May 20143:31 pmRNSResult of Annual Meeting
29th Apr 20144:44 pmRNSBlocklisting Interim Review
22nd Apr 201410:02 amRNSAnnual Report & Accounts Posted
20th Mar 20147:00 amRNS2013 Preliminary Results
30th Jan 20147:00 amRNSYear End Trading Update & Contract Wins
10th Dec 20133:29 pmRNSTotal Voting Rights
4th Dec 20133:24 pmRNSHolding(s) in Company
26th Nov 20137:00 amRNSFast-to-market lease programme yields new leasings
30th Oct 20133:21 pmRNSDirector/PDMR Shareholding
29th Oct 20131:56 pmRNSBlocklisting Interim Review
16th Oct 20133:12 pmRNSDirector Shareholding / Warrant Exercise
3rd Oct 20137:00 amRNSInvestor Presentation
12th Sep 20137:00 amRNSHalf Year Results Statement
19th Aug 20139:06 amRNSNotice of Results
7th Aug 20139:29 amRNSBalance of respective lines of stock
10th Jun 20135:16 pmRNSChange of Main Office Address
3rd Jun 20133:19 pmRNSTotal Voting Rights
28th May 20135:02 pmRNSHolding(s) in Company
28th May 20132:54 pmRNSDirector/PDMR Shareholding
24th May 20138:52 amRNSHolding(s) in Company
14th May 20132:14 pmRNSResult of Annual Meeting
14th May 20137:00 amRNSOperational Update & Directorate Change
9th May 20137:00 amRNSExercise of Warrant
23rd Apr 201312:49 pmRNSApplication for Block Admission
19th Apr 20137:00 amRNSAnnual Financial Report/Directorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.